Your browser doesn't support javascript.
loading
Correction to: Number-needed-to-treat analysis of clinical progression in patients with metastatic castration-resistant prostate cancer in the STRIVE and TERRAIN trials.
Schultz, Neil M; Shore, Neal D; Chowdhury, Simon; Klotz, Laurence H; Concepcion, Raoul S; Penson, David F; Karsh, Lawrence I; Yang, Hongbo; Brown, Bruce A; Barlev, Arie; Flanders, Scott C.
Afiliación
  • Schultz NM; Astellas Pharma, Inc., 1 Astellas Way, Northbrook, IL, 60062, USA. neil.schultz@astellas.com.
  • Shore ND; Carolina Urologic Research Center, Myrtle Beach, SC, USA.
  • Chowdhury S; Guy's, King's, and St. Thomas' Hospitals, London, UK.
  • Klotz LH; Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada.
  • Concepcion RS; Urology Associates, P.C, Nashville, TN, USA.
  • Penson DF; Vanderbilt University Medical Center, Nashville, TN, USA.
  • Karsh LI; The Urology Center of Colorado, Denver, CO, USA.
  • Yang H; Analysis Group, Inc., Boston, MA, USA.
  • Brown BA; Astellas Pharma, Inc., 1 Astellas Way, Northbrook, IL, 60062, USA.
  • Barlev A; Medivation, Inc., San Francisco, CA, USA.
  • Flanders SC; Pfizer, Inc., New York, NY, USA.
BMC Urol ; 18(1): 84, 2018 10 01.
Article en En | MEDLINE | ID: mdl-30285696

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: BMC Urol Asunto de la revista: UROLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: BMC Urol Asunto de la revista: UROLOGIA Año: 2018 Tipo del documento: Article País de afiliación: Estados Unidos